Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’.
Merilee Kern, MBA, Brand Analyst, Strategist and Futurist, and Forbes Business Council Member09.09.21
Spray drying is an established particle engineering technology that offers several advantages over other methods used for improving API bioavailability.
Will leverage Innovent's therapeutic antibody portfolio and discovery capability against undisclosed oncology targets in combination with Bolt's ISAC technology
Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’
Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.
State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.
Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.
Evotec's first commercial biomanufacturing facility in Europe is anticipated to deliver much needed capacity for biotherapeutic development and manufacturing.
Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.
35-year pharmaceutical industry veteran brings deep industry expertise and a track record of building successful, client-centric, growth organizations.
Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.
Will focus on clinical and commercial clients, especially as Cognate expands its business with allogeneic and autologous on-demand cell and gene therapies.
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".
Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups01.05.21
Karen will work to further expand the company's contract manufacturing business, which delivers GMP materials to third parties developing COVID-19 vaccines.
Launches PyroCell MAT System for in vitro Pyrogen testing to help ensure safety of parenteral pharmaceuticals during development, manufacture and release.
To increase small molecule manufacturing capacity for additional scale-up of CleanCap messenger RNA capping technology for vaccine and therapeutic programs.
CDMO Binex responsible for large-scale manufacturing of clinical investigational material for PharmAbcine for its global Phase 2 trials of olinvacimab.
Hiring is up, recruiters say, and soft skills are in short supply. Survey respondents say they’re happy now, but will likely change employers within five years.
David A. Linn has been named director of business intelligence and business development for Jubilant HollisterStier’s Contract Manufacturing & Services Division.
Fujifilm Corp. and Merck have entered into a definitive agreement under which Fujifilm will acquire the Merck BioManufacturing Network, a provider of contract manufacturing and development services for the biopharma industry.
Grant Gilker has been named general manager of operations at DPT’s Center of Excellence for semi-solids and liquids manufacturing facility in San Antonio, TX.
An affiliate of Sun European Partners, LLP has entered into an agreement to acquire NextPharma Technologies Holding Ltd., a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and bi
Pharmaceutical Packaging Systems sales were $200.9 million in the quarter (+6%) attributed to growth in sales of Westar-processed, FluroTec- and Teflon-coated products, as well as sales of Envision.
NextPharma has engaged the services of Ron Collins to represent its business development affairs in the eastern part of the U.S. and Canada in order to meet increased demand for its contract outsourcing services.
Alliance Medical Products, Inc. (AMP) has opened its East Coast sales office located in Howell, NJ, and appointed Thomas J. Puskar as associate director and East Coast account executive.
Cory Lewis has been named director of business development for the global biopharmaceutical contract development and manufacturing division of Cook Medical.
The parenteral drug sector is driven by new cancer drugs and a considerable number of biologics. Veteran performers, like Baxter Biopharma, brace for growth.
Biologics capacity may be in short supply just as biopharma products head to commercial manufacture. Learn how to plan protein production in a resource-constrained environment